These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3683183)

  • 1. Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion.
    Crist DM; Peake GT; Mackinnon LT; Sibbitt WL; Kraner JC
    Metabolism; 1987 Dec; 36(12):1115-7. PubMed ID: 3683183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body composition response to exogenous GH during training in highly conditioned adults.
    Crist DM; Peake GT; Egan PA; Waters DL
    J Appl Physiol (1985); 1988 Aug; 65(2):579-84. PubMed ID: 3170408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous human growth hormone reduces body fat in obese women.
    Skaggs SR; Crist DM
    Horm Res; 1991; 35(1):19-24. PubMed ID: 1916649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental growth hormone increases the tumor cytotoxic activity of natural killer cells in healthy adults with normal growth hormone secretion.
    Crist DM; Kraner JC
    Metabolism; 1990 Dec; 39(12):1320-4. PubMed ID: 2246974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.
    Snyder DK; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1989 Oct; 69(4):745-52. PubMed ID: 2778033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
    Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of human growth hormone (GH) administration in GH-deficient adults: a 20-day metabolic ward study.
    Valk NK; vd Lely AJ; de Herder WW; Lindemans J; Lamberts SW
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1070-6. PubMed ID: 7525625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
    Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
    J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
    Snyder DK; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) regulation of circulating insulin-like growth factor-I levels during sexual maturation of the GH-deficient dwarf (dw/dw) male rat.
    Crawford BA; Dobbie P; Bass JJ; Lewitt MS; Baxter RC; Handelsman DJ
    J Endocrinol; 1994 Jun; 141(3):393-401. PubMed ID: 7520929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation.
    Soliman AT; Hassan AE; Aref MK; Hintz RL; Rosenfeld RG; Rogol AD
    Pediatr Res; 1986 Nov; 20(11):1122-30. PubMed ID: 3099250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro effects of GH and IGF-1 on natural cytostatic activity].
    Valtorta A; Moretta A; Fiori A; Biscaldi I
    Medicina (Firenze); 1990; 10(2):149-50. PubMed ID: 2273948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
    Vittone J; Blackman MR; Busby-Whitehead J; Tsiao C; Stewart KJ; Tobin J; Stevens T; Bellantoni MF; Rogers MA; Baumann G; Roth J; Harman SM; Spencer RG
    Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The beneficial effects of growth hormone replacement therapy on elderly men].
    Kozakowski J; Adamkiewicz M; Krassowski J; Zgliczyński S
    Pol Merkur Lekarski; 1999 Mar; 6(33):131-4. PubMed ID: 10365596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary energy source and level on serum growth hormone, insulin-like growth factor 1, growth and body composition in beef heifers.
    Houseknecht KL; Boggs DL; Campion DR; Sartin JL; Kiser TE; Rampacek GB; Amos HE
    J Anim Sci; 1988 Nov; 66(11):2916-23. PubMed ID: 2852186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
    Hilding A; Brismar K; Degerblad M; Thorén M; Hall K
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.
    de Boer H; Blok GJ; Voerman B; Derriks P; van der Veen E
    Int J Obes Relat Metab Disord; 1996 Jun; 20(6):580-7. PubMed ID: 8782736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
    Tanaka K; Inoue S; Numata K; Okazaki H; Nakamura S; Takamura Y
    Metabolism; 1990 Sep; 39(9):892-6. PubMed ID: 2118219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.